DK1393741T3 - Lagerstabil, flydende fibrinogen-formulering - Google Patents

Lagerstabil, flydende fibrinogen-formulering

Info

Publication number
DK1393741T3
DK1393741T3 DK03016766.2T DK03016766T DK1393741T3 DK 1393741 T3 DK1393741 T3 DK 1393741T3 DK 03016766 T DK03016766 T DK 03016766T DK 1393741 T3 DK1393741 T3 DK 1393741T3
Authority
DK
Denmark
Prior art keywords
stable
fibrinogen formulation
liquid fibrinogen
formulation
liquid
Prior art date
Application number
DK03016766.2T
Other languages
English (en)
Inventor
Volker Gawantka
Karlheinz Enssle
Hubert Metzner
Uwe Liebing
Gerhardt Kumpe
Stefan Schulte
Original Assignee
Csl Behring Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=31496745&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1393741(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Csl Behring Gmbh filed Critical Csl Behring Gmbh
Application granted granted Critical
Publication of DK1393741T3 publication Critical patent/DK1393741T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK03016766.2T 2002-08-13 2003-07-23 Lagerstabil, flydende fibrinogen-formulering DK1393741T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10237643 2002-08-13
DE10261126A DE10261126A1 (de) 2002-08-13 2002-12-20 Lagerungsstabile, flüssige Fibrinogen-Formulierung

Publications (1)

Publication Number Publication Date
DK1393741T3 true DK1393741T3 (da) 2010-08-09

Family

ID=31496745

Family Applications (1)

Application Number Title Priority Date Filing Date
DK03016766.2T DK1393741T3 (da) 2002-08-13 2003-07-23 Lagerstabil, flydende fibrinogen-formulering

Country Status (11)

Country Link
US (1) US7045601B2 (da)
EP (1) EP1393741B1 (da)
JP (1) JP4824906B2 (da)
KR (1) KR101082769B1 (da)
AT (1) ATE466589T1 (da)
AU (1) AU2003234743B2 (da)
CA (1) CA2437064C (da)
DE (2) DE10261126A1 (da)
DK (1) DK1393741T3 (da)
ES (1) ES2344687T3 (da)
IL (1) IL157360A (da)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2404682T3 (es) 2003-12-11 2013-05-28 Isto Technologies Inc. Sistema de cartílago particulado
JP5292533B2 (ja) 2005-08-26 2013-09-18 ジンマー・インコーポレイテッド インプラントおよび関節疾患の治療、置換および治療方法
FR2894831B1 (fr) * 2005-12-16 2008-02-15 Lab Francais Du Fractionnement Colle biologique exempte de thrombine et son utilisation comme medicament.
MX2009006369A (es) 2006-12-15 2010-02-24 Lifebond Ltd Apositos y selladores hemostaticos de gelatina-transglutaminasa.
US8163549B2 (en) 2006-12-20 2012-04-24 Zimmer Orthobiologics, Inc. Method of obtaining viable small tissue particles and use for tissue repair
EP2131776A1 (en) * 2007-03-30 2009-12-16 Thrombodyne Inc. Methods of making concentrated fibrinogen containing compositions and associated systems for preparing fibrin glue
AU2008240191B2 (en) 2007-04-12 2013-09-19 Zimmer, Inc. Compositions and methods for tissue repair
WO2008135963A2 (en) * 2007-05-02 2008-11-13 Hemogem Inc. Fibrinogen for treatment of bleeding in trauma and platelet disorders
WO2009111615A2 (en) * 2008-03-05 2009-09-11 Thrombovision, Inc. Systems for measuring properties of a physiological fluid suspension
WO2009134130A2 (en) 2008-05-02 2009-11-05 Pharming Intellectual Property Bv Treatment of bleeding with low half-life fibrinogen
EP2487206A3 (en) 2008-06-18 2012-11-28 Lifebond Ltd Cross-linkable gelatin-based compositions
WO2009155626A2 (de) * 2008-06-23 2009-12-30 Bio-Products & Bio-Engineering Ag Lagerstabiles, funktionell intaktes fibrinogen
PE20151205A1 (es) * 2008-08-15 2015-08-31 Ironwood Pharmaceuticals Inc Formulaciones que contienen linaclotida para administracion oral
JP2010069031A (ja) * 2008-09-19 2010-04-02 Chemo Sero Therapeut Res Inst シート状フィブリン糊接着剤
GB0818228D0 (en) * 2008-10-06 2008-11-12 Avecia Biolog Ltd Purification process
CA2742817A1 (en) 2008-11-20 2010-05-27 Biogen Idec Ma Inc. Arginine inactivation of viruses
CA2770077A1 (en) * 2009-08-06 2011-02-10 Ironwood Pharmaceuticals, Inc. Formulations comprising linaclotide
JP5796860B2 (ja) 2009-12-22 2015-10-21 ライフボンド リミテッドＬｉｆｅｂｏｎｄ Ｌｔｄ 架橋マトリックスの特性を調節するための酵素的架橋剤の改変
EA201290799A1 (ru) 2010-02-17 2013-03-29 Айронвуд Фармасьютикалз, Инк. Лечение желудочно-кишечных расстройств
CA2807012A1 (en) 2010-08-05 2012-02-09 Lifebond Ltd. Dry composition wound dressings and adhesives
RS59978B1 (sr) 2010-08-11 2020-03-31 Ironwood Pharmaceuticals Inc Stabilne formulacije linaklotida
WO2013025969A1 (en) 2011-08-17 2013-02-21 Ironwood Pharmaceuticals, Inc. Treatments for gastrointestinal disorders
KR101127127B1 (ko) * 2011-10-27 2012-03-21 주식회사 녹십자 고농도 피브리노겐 용액의 제조 방법 및 이를 이용한 피브린 실란트 제품의 제조방법
US8900822B2 (en) * 2011-11-21 2014-12-02 Ethicon, Inc. Fibrinogen assay
US8999376B2 (en) 2012-02-03 2015-04-07 Xcede Technologies, Inc. Tissue patch
ES2642383T3 (es) 2012-03-13 2017-11-16 Octapharma Ag Procedimiento mejorado de producción de fibrinógeno y fibrinógeno producido por el mismo
WO2014055552A1 (en) 2012-10-03 2014-04-10 Csl Behring Llc A method of purifying proteins
US10188965B2 (en) 2012-12-05 2019-01-29 Csl Behring Gmbh Hydrophobic charge induction chromatographic depletion of a protein from a solution
US20140154233A1 (en) 2012-12-05 2014-06-05 Csl Limited Method of purifying therapeutic proteins
US20140178343A1 (en) 2012-12-21 2014-06-26 Jian Q. Yao Supports and methods for promoting integration of cartilage tissue explants
IL230151A0 (en) * 2013-12-24 2014-09-30 Omrix Biopharmaceuticals Ltd One-component fibrin glue containing a polymerization inhibitor
ES2719505T3 (es) * 2013-12-27 2019-07-10 Japan Blood Products Organization Línea altamente productora de fibrinógeno recombinante y método para su producción
IL231230A0 (en) 2014-02-27 2014-08-31 Omrix Biopharmaceuticals Ltd Fibrinogen preparation
IL231792A0 (en) 2014-03-27 2014-08-31 Omrix Biopharmaceuticals Ltd Device and method for the preparation and administration of one-component fibrin glue
US9833538B2 (en) 2015-08-07 2017-12-05 Xcede Technologies, Inc. Adhesive compositions and related methods
US9540548B1 (en) 2015-08-07 2017-01-10 Xcede Technologies, Inc. Adhesive compositions and related methods
CA2994959A1 (en) 2015-08-07 2017-02-16 Xcede Technologies, Inc. Adhesive compositions and related methods
FR3053592B1 (fr) * 2016-07-06 2020-05-29 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Fibrinogene liquide stable
WO2018007530A1 (en) * 2016-07-06 2018-01-11 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Anti-fibrinogen aptamers and uses thereof
FR3061020B1 (fr) * 2016-12-22 2019-05-17 Laboratoire Francais Du Fractionnement Et Des Biotechnologies Composition de fibrinogene humain
US20200237652A1 (en) 2017-08-08 2020-07-30 Csl Behring Ag Hemopexin formulations
CN111956788A (zh) * 2020-09-22 2020-11-20 上海利康瑞生物工程有限公司 一种猪源纤维蛋白原冻干制剂、制备工艺及其应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE6930394U (de) 1968-11-06 1970-01-22 American Standard Inc Eine Ges Auswurfmundstueck fuer stroemungsmittel
DE3230849A1 (de) 1982-08-19 1984-02-23 Behringwerke Ag, 3550 Marburg Pasteurisiertes human-fibrinogen (hf) und verfahren zu dessen herstellung
DE3622642A1 (de) 1986-07-05 1988-01-14 Behringwerke Ag Einkomponenten-gewebekleber sowie verfahren zu seiner herstellung
DE3734923C1 (de) 1987-10-15 1989-01-26 Biotest Pharma Gmbh Verfahren zur Herstellung einer sterilen Plasmaproteinloesung,die Fibrinogen und den Gerinnungsfaktor XIII enthaelt
DE4202667C1 (da) * 1992-01-29 1993-05-13 Behringwerke Ag, 3550 Marburg, De
FR2686883B1 (fr) * 1992-02-04 1994-05-13 Aquitaine Develop Transf Sanguin Procede de fabrication de fibrinogene de tres haute purete, fibrinogene de tres haute purete obtenu ainsi qu'une composition pharmaceutique le contenant.
JP3867931B2 (ja) * 1993-11-08 2007-01-17 財団法人化学及血清療法研究所 液状フィブリノゲン製剤
US5411885A (en) * 1993-12-17 1995-05-02 New York Blood Center, Inc. Methods for tissue embedding and tissue culturing
US5639940A (en) 1994-03-03 1997-06-17 Pharmaceutical Proteins Ltd. Production of fibrinogen in transgenic animals
SE9501189D0 (sv) 1995-03-31 1995-03-31 Pharmacia Ab Protein formulation
US5925738A (en) 1995-12-01 1999-07-20 The American National Red Cross Methods of production and use of liquid formulations of plasma proteins
DE19617369A1 (de) * 1996-04-30 1997-11-06 Immuno Ag Lagerstabile Fibrinogen-Präparate
ATE234642T1 (de) 1998-05-01 2003-04-15 Zymogenetics Inc Vollständig rekombinanter gewebekleber
WO2001048016A1 (en) 1999-12-23 2001-07-05 Csl Limited Separation of fibrinogen from plasma proteases
DE10012732A1 (de) 2000-03-18 2001-09-20 Aventis Behring Gmbh Thrombin-Zubereitungen und Verfahren zu ihrer Herstellung
JP4733283B2 (ja) * 2000-03-28 2011-07-27 一般財団法人化学及血清療法研究所 液状フィブリノゲン製剤

Also Published As

Publication number Publication date
AU2003234743B2 (en) 2008-07-31
CA2437064A1 (en) 2004-02-13
DE10261126A1 (de) 2004-03-04
ATE466589T1 (de) 2010-05-15
EP1393741B1 (de) 2010-05-05
JP4824906B2 (ja) 2011-11-30
DE50312689D1 (de) 2010-06-17
ES2344687T3 (es) 2010-09-03
IL157360A (en) 2011-12-29
EP1393741A1 (de) 2004-03-03
KR101082769B1 (ko) 2011-11-11
KR20040015692A (ko) 2004-02-19
AU2003234743A1 (en) 2004-03-04
US7045601B2 (en) 2006-05-16
JP2004075682A (ja) 2004-03-11
IL157360A0 (en) 2004-02-19
US20050080009A1 (en) 2005-04-14
CA2437064C (en) 2013-06-11

Similar Documents

Publication Publication Date Title
DK1393741T3 (da) Lagerstabil, flydende fibrinogen-formulering
BRPI0402760A (pt) Composição microbicida
RS52390B (en) SYNERGISTIC HERBICIDE PREPARATIONS CONTAINING MESOTRION
BR0317715A (pt) Composições e processos de uso de collajolie
BR0215405A (pt) Composições e processos de uso de collajolie
SE0100901D0 (sv) New composition
SV2003001144A (es) FORMAS CRISTALINAS DE LA SAL DE CALCIO DEL ACIDO [R-(R*,R*)]-2-(4-FLUOROFENIL)-ß,ô-DIHIDROXI-5-(1-METILETIL)-3-FENIL-4[(FENILAMINO)CARBONIL]-1H-PIRROL-1-HEPTANOICO (2:1) REF. PC430-01FJT
HUP9900152A2 (hu) Alkoholalapú mikrobaellenes kozmetikai készítmény és alkalmazása
BRPI0412684A (pt) compostos ppar-ativos
IL173059A0 (en) (2s,4s)-4-fluoro-1-[4-fluoro-beta-(4-fluorophenyl)-l-phenylalanyl]-2-pyrrolidinecarbonitrile p-toluenesulfonic acid salt and anhydrous crystalline forms thereof
PT931788E (pt) Inibidores de metaloprotease
NO307336B1 (no) 2-[(Dihydro)pyrazolyl-3'-oksylmetylen]anilider, anvendelse derav, samt middel inneholdende forbindelsen og mellomprodukter for fremstilling av forbindelsen
DE50202328D1 (de) Amidofunktionelle aminopolydiorganosiloxane
ATE266662T1 (de) Nf-kappa b inhibitoren, die indanderivate als aktiven bestandteil enthalten
BR0112389A (pt) Pó para condensador
TW200605786A (en) Dermally applicable liquid formulations for controlling parasitic arthropods on animals
MY122877A (en) Composition.
FR2848116B1 (fr) Composition cosmetique comprenant un inhibiteur des metallo-proteinases et un lipopeptide.
BR0210348A (pt) Material polimérico, contendo um ácido latente
BR9910539A (pt) Derivados de 2 - (2 - clorofenil) - 3,4 - dihidro - 2h - pirrol
ATE433458T1 (de) Modulatoren von ship-1
ES2180319T3 (es) Utilizacion de derivados de metilenbisoxazolidina y composiciones de los mismos.
DE60101486D1 (de) Verwendung von Polyaminosäurederivate als Konservierungsmittel
EA200401442A1 (ru) Композиция, содержащая яванское цитронелловое масло, и ее применение в качестве репеллента от насекомых
AR046120A1 (es) Fomulaciones fungicidas que contienen cobre